4//SEC Filing
Zynerba Pharmaceuticals, Inc. 4
Accession 0001192482-15-000394
CIK 0001621443operating
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 1:48 PM ET
Size
7.0 KB
Accession
0001192482-15-000394
Insider Transaction Report
Form 4
BARON RICHARD A
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option
2015-09-11−15,957→ 47,872 totalExercise: $3.98Exp: 2025-01-02→ Common Stock (15,957 underlying) - Exercise/Conversion
Common Stock
2015-09-11$3.98/sh+15,957$63,509→ 15,957 total
Footnotes (1)
- [F1]The stock option vested as to 25% of the common stock (15,957 shares) as of the date of the closing of the Issuer's initial public offering, with the balance vesting in twelve equal quarterly installments thereafter.
Documents
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001621443
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 1:48 PM ET
- Size
- 7.0 KB